HeartSciences (HSCS) EBIAT (2021 - 2025)
Historic EBIAT for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.
- HeartSciences' EBIAT fell 1285.94% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.0 million, marking a year-over-year decrease of 1851.65%. This contributed to the annual value of -$8.8 million for FY2025, which is 3270.18% down from last year.
- According to the latest figures from Q4 2025, HeartSciences' EBIAT is -$2.4 million, which was down 1285.94% from -$2.1 million recorded in Q3 2025.
- In the past 5 years, HeartSciences' EBIAT ranged from a high of -$501851.0 in Q3 2021 and a low of -$2.5 million during Q1 2025
- Its 5-year average for EBIAT is -$1.7 million, with a median of -$1.8 million in 2022.
- Its EBIAT has fluctuated over the past 5 years, first tumbled by 21350.0% in 2022, then surged by 2049.43% in 2023.
- Over the past 5 years, HeartSciences' EBIAT (Quarter) stood at -$1.0 million in 2021, then tumbled by 74.58% to -$1.8 million in 2022, then increased by 3.22% to -$1.7 million in 2023, then decreased by 19.13% to -$2.1 million in 2024, then dropped by 12.86% to -$2.4 million in 2025.
- Its EBIAT was -$2.4 million in Q4 2025, compared to -$2.1 million in Q3 2025 and -$2.1 million in Q2 2025.